Literature DB >> 30005008

HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients.

Jonathan L Golob1,2, Joshua Stern3, Sarah Holte3, Mari M Kitahata1, Heidi M Crane1,4, Robert W Coombs1,5, Erin Goecker5, Ann E Woolfrey6, Robert D Harrington1.   

Abstract

BACKGROUND AND
METHOD: We examined specimens from 111 HIV-infected participants virally suppressed on ART for a minimum of 5 years who had donated serial peripheral blood mononuclear cell (PBMC) specimens to the University of Washington/Fred Hutch Center for AIDS Research (CFAR) Specimen Repository. We determined the HIV proviral copy number per million PBMCs, corrected for CD4 cell count, in 477 specimens collected after a minimum of 5 years of follow-up and up to 15.5 years of clinical viral suppression. Generalized estimating equation regression was used to examine the association between the reservoir size and time, age at study entry, antiretroviral regimen, and risk factors for HIV acquisition. RESULTS AND
CONCLUSION: We found that the inter-participant baseline HIV DNA level varied widely between 0.01 and 4.8 pol-copies per microgram genomic DNA and per CD4 cell number/micoliter; the HIV DNA level declined with time (half-life was estimated at 12 years, 95% confidence interval of 6.2-240 years); the HIV DNA level was lower for those who achieved viral suppression at a younger age; and the HIV DNA level was not affected by the specific antiretroviral regimen used to achieve and maintain suppression.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30005008      PMCID: PMC6136948          DOI: 10.1097/QAD.0000000000001948

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

3.  Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies.

Authors:  Amanda M Crooks; Rosalie Bateson; Anna B Cope; Noelle P Dahl; Morgan K Griggs; JoAnn D Kuruc; Cynthia L Gay; Joseph J Eron; David M Margolis; Ronald J Bosch; Nancie M Archin
Journal:  J Infect Dis       Date:  2015-04-15       Impact factor: 5.226

4.  Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

Authors:  Julio C C Lorenzi; Yehuda Z Cohen; Lillian B Cohn; Edward F Kreider; John P Barton; Gerald H Learn; Thiago Oliveira; Christy L Lavine; Joshua A Horwitz; Allison Settler; Mila Jankovic; Michael S Seaman; Arup K Chakraborty; Beatrice H Hahn; Marina Caskey; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

5.  The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

Authors:  B Ramratnam; J E Mittler; L Zhang; D Boden; A Hurley; F Fang; C A Macken; A S Perelson; M Markowitz; D D Ho
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

6.  Electronic human immunodeficiency virus (HIV) clinical reminder system improves adherence to practice guidelines among the University of Washington HIV Study Cohort.

Authors:  Mari M Kitahata; Peter W Dillingham; Nathorn Chaiyakunapruk; Susan E Buskin; Jeffrey L Jones; Robert D Harrington; Thomas M Hooton; King K Holmes
Journal:  Clin Infect Dis       Date:  2003-03-04       Impact factor: 9.079

7.  Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.

Authors:  Szu-Han Huang; Yanqin Ren; Allison S Thomas; Dora Chan; Stefanie Mueller; Adam R Ward; Shabnum Patel; Catherine M Bollard; Conrad Russell Cruz; Sara Karandish; Ronald Truong; Amanda B Macedo; Alberto Bosque; Colin Kovacs; Erika Benko; Alicja Piechocka-Trocha; Hing Wong; Emily Jeng; Douglas F Nixon; Ya-Chi Ho; Robert F Siliciano; Bruce D Walker; R Brad Jones
Journal:  J Clin Invest       Date:  2018-01-22       Impact factor: 14.808

8.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

9.  CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells.

Authors:  Leslie R Cockerham; Janet D Siliciano; Elizabeth Sinclair; Una O'Doherty; Sarah Palmer; Steven A Yukl; Matt C Strain; Nicolas Chomont; Frederick M Hecht; Robert F Siliciano; Douglas D Richman; Steven G Deeks
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

10.  Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth.

Authors:  Maja Kiselinova; Ward De Spiegelaere; Maria Jose Buzon; Eva Malatinkova; Mathias Lichterfeld; Linos Vandekerckhove
Journal:  PLoS Pathog       Date:  2016-03-03       Impact factor: 6.823

View more
  13 in total

Review 1.  The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies.

Authors:  Lillian B Cohn; Nicolas Chomont; Steven G Deeks
Journal:  Cell Host Microbe       Date:  2020-04-08       Impact factor: 21.023

2.  Impact of Early Antiretroviral Therapy on Detection of Cell-Associated HIV-1 Nucleic Acid in Blood by the Roche Cobas TaqMan Test.

Authors:  Linda L Jagodzinski; Mark M Manak; Holly R Hack; Ying Liu; Jennifer A Malia; Joanna Freeman; Nittaya Phanuphak; Mark de Souza; Eugène D Kroon; Donn J Colby; Nitiya Chomchey; Michelle A Lally; Nelson L Michael; Jintanat Ananworanich; Sheila A Peel
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

3.  HIV DNA decay during antiretroviral therapy: lessons from a clinic-based cohort study.

Authors:  Nikolaus Jilg; Peter W Hunt; Rajesh T Gandhi
Journal:  AIDS       Date:  2018-09-24       Impact factor: 4.632

Review 4.  The Contributions of Clinical Pharmacology to HIV Cure Research.

Authors:  Courtney V Fletcher; Shetty Ravi Dyavar; Arpan Acharya; Siddappa N Byrareddy
Journal:  Clin Pharmacol Ther       Date:  2021-04-18       Impact factor: 6.903

5.  Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.

Authors:  Cecilia Sgadari; Paolo Monini; Antonella Tripiciano; Orietta Picconi; Anna Casabianca; Chiara Orlandi; Sonia Moretti; Vittorio Francavilla; Angela Arancio; Giovanni Paniccia; Massimo Campagna; Stefania Bellino; Marianna Meschiari; Silvia Nozza; Laura Sighinolfi; Alessandra Latini; Antonio Muscatello; Annalisa Saracino; Massimo Di Pietro; Massimo Galli; Aurelio Cafaro; Mauro Magnani; Fabrizio Ensoli; Barbara Ensoli
Journal:  Front Immunol       Date:  2019-02-13       Impact factor: 7.561

Review 6.  Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease.

Authors:  Aurelio Cafaro; Antonella Tripiciano; Orietta Picconi; Cecilia Sgadari; Sonia Moretti; Stefano Buttò; Paolo Monini; Barbara Ensoli
Journal:  Vaccines (Basel)       Date:  2019-08-26

7.  Reliability of plasma HIV viral load testing beyond 24 hours: Insights gained from a study in a routine diagnostic laboratory.

Authors:  Diana Hardie; Stephen Korsman; Sharifa Ameer; Lara Vojnov; Nei-Yuan Hsiao
Journal:  PLoS One       Date:  2019-07-03       Impact factor: 3.240

8.  Defective HIV-1 proviruses produce viral proteins.

Authors:  Hiromi Imamichi; Mindy Smith; Joseph W Adelsberger; Taisuke Izumi; Francesca Scrimieri; Brad T Sherman; Catherine A Rehm; Tomozumi Imamichi; Alice Pau; Marta Catalfamo; Anthony S Fauci; H Clifford Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-06       Impact factor: 11.205

9.  HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design.

Authors:  Ángel Bayón-Gil; Maria C Puertas; Víctor Urrea; Lucía Bailón; Sara Morón-López; Patricia Cobarsí; Christian Brander; Beatriz Mothe; Javier Martinez-Picado
Journal:  J Antimicrob Chemother       Date:  2020-08-01       Impact factor: 5.790

10.  Dynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan women.

Authors:  Mark D Pankau; Daniel B Reeves; Elias Harkins; Keshet Ronen; Walter Jaoko; Kishor Mandaliya; Susan M Graham; R Scott McClelland; Frederick A Matsen Iv; Joshua T Schiffer; Julie Overbaugh; Dara A Lehman
Journal:  PLoS Pathog       Date:  2020-02-05       Impact factor: 7.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.